欧美一区二区精品少妇,日韩熟女av一二三区免费看,午夜色啪久久久久久性,av中文字幕不卡无码

您的當(dāng)前位置:首頁(yè) > Smartox-Biotech
Smartox-Biotech

Smartox Biotechnology

  

我要查看Smartox Biotechnology產(chǎn)品信息http://m.hbhuard.cn/goodsid/goodsview/19948370.html



Smartox Biotechnology

離子通道研究用多肽毒素的專業(yè)化生產(chǎn)商

Smartox Biotechnology是全球**一家專門(mén)生產(chǎn)動(dòng)物毒液多肽毒素,用于細(xì)胞離子通道功能研究的生物醫(yī)藥公司。多肽毒素在生物制藥領(lǐng)域具有重要的使用價(jià)值。

Smartox Biotechnology2009年由來(lái)自Grenoble神經(jīng)科學(xué)研究所(Grenoble Institute of Neuroscience)Michel de waard博士創(chuàng)立,Smartox Biotechnology專門(mén)研究動(dòng)物毒液,制作合成多種毒液中的多肽成分(常稱為毒素)。De Waard博士研究離子通道與毒素多肽的關(guān)系,尤其是鑒定、開(kāi)發(fā)毒素多肽作為治療性分子或細(xì)胞穿透肽(cell penetrating peptides, CPP)。其研究團(tuán)隊(duì)在毒液分離,藥理性活性肽鑒定、富半胱氨酸肽定性、制作和優(yōu)化等方面具有獨(dú)特、豐富的經(jīng)驗(yàn)。2010年,Smartox Biotechnolgy被法國(guó)研究部(Ministry of Research)授予“新興企業(yè)OSEO獎(jiǎng)(OSEO prize for emerging businesses)”。

總之,Smartox Biotechnology提供一系列高質(zhì)量、具開(kāi)創(chuàng)價(jià)值的多肽毒素。這些化合物在離子通道 研究中具有高的親和性和選擇性,是相應(yīng)領(lǐng)域科學(xué)研究理想的生物毒素提供商和貼心的合作伙伴。

 Smartox Biotechnology毒素產(chǎn)品包括:

鈉離子通道(Sodium channel)

Toxin name

Catalog #

Target

Phrixotoxin-3

13PHX003

Selective blocker of Nav1.2

μ-conotoxin GIIIB

CON020

Selective blocker of Nav1.4

μ-conotoxin CnIIIC

CON021

Selective blocker of Nav1.4

μ-conotoxin PIIIA

08CON006

Selective blocker of Nav1.4

Jingzhaotoxin-III

12JZH003

Selective blocker of Nav1.5

ProTx-II

07PTX002

Selective blocker of Nav1.7

ProTx-II Biotin

12PTB002

Selective blocker of Nav1.7

ProTx-I

12PTX001

Blocker of Nav1.8, Nav1.2, Nav1.5, Nav1.7

Huwentoxin-I

07HWT001

Blocker of TTX-S

Huwentoxin-IV

08HWT002

Blocker of TTX-S

Hainantoxin-III

13HTX003

Blocker of TTX-S

Hainantoxin-IV

12HTX001

Blocker of TTX-S

GsAF-I

12GSF001

Blocker of TTX-S

GsAF-II

12GSF002

Blocker of TTX-S

 

鉀離子通道(Potassium channel)

KCa channels

Toxin name

Catalog #

Target

Description

Apamin

08APA001

SK1, SK2, SK3

 

Charybdotoxin

11CHA001

KCa1.1, KCa3.1 - Kv1.2, Kv1.3, Kv1.6

 

Iberiotoxin

12IBX001

KCa1.1

 

Leiurotoxin 1 (Scyllatoxin)

10LEI001

SK1, SK2, SK3

 

Tamapin

10TAM001

SK1, SK2, SK3

 

Kaliotoxin-1

08KTX002

BK, Kv1.1, Kv1.2, Kv1.3

 
 

Kv channels

ShK

08SHK001

Kv1.3, Kv1.1, Kv1.4, Kv1.6

 

TMR-ShK

SAT001

Kv1.3, Kv1.1

 

Margatoxin

08MAG001

Kv1.3

 

(Dap22)-ShK

13SHD001

Kv1.3

 

ADWX-1

13ADW001

Kv1.3

 

HsTx1

08NEU001

Kv1.3, Kv1.2

 

Agitoxin-2

13AGI002

Kv1.3, Kv1.1

 

Maurotoxin

08MAR001

Kv1.2, KCa3.1

 

Guangxitoxin 1E

11GUA002

Kv2.1, Kv2.2

 

Stromatoxin 1 NEW

SCT01

Kv2.1, Kv2.2

 

Kaliotoxin-1

08KTX002

BK, Kv1.1, Kv1.2, Kv1.3

 

Charybdotoxin

11CHA001

KCa1.1, KCa3.1 - Kv1.2, Kv1.3, Kv1.6

 

Phrixotoxin-2

PHX002

Kv4.2, Kv4.3

 

AmmTx3 NEW

AMX001

A-type potassium channels

 
 

Inwardly rectifying potassium channels

TertiapinQ

08TER001

Kir1.1, Kir3.1/3.4, Kir3.1/3.2-KCa1.1

 
 

hERG/Kv11.1

BeKm-1

13BEK001

ERG1

 

 

鈣離子通道(Calcium channel)

High voltage-gated Ca2+ channels

Toxin name

Catalog#

Target

Description

ω-agatoxin IVA

11AGA001

P/Qtype

 

ω-Conotoxin MVIIC

08CON002

P/Qtype, N-type

 

ω-Conotoxin MVIIA

08CON001

N-type

 

ω-Conotoxin GVIA

08CON003

N-type

 

ω-Conotoxin SO3

08CON013

N-type

 

Huwentoxin I

07HWT001

N-type

 

ProTx-II

07PTX002

T-type, L-type

 
 

Intermediate voltage-gated Ca2+ channels

SNX482

08SNX002

R-type

 
 

Low voltage-gated Ca2+ channels

ProTx-I

12PTX001

T-type

 

ProTx-II

07PTX002

T-type, L-type

 
 

Ryanodine receptors

Maurocalcine

07PAU001

Ryr1

 

 

氯離子通道(Chloride channel)

Toxin name

Catalog #

Target

Description

Chlorotoxin

08CHL001

Blocker of small conductance Cl- channels

 

GaTx1

13GTX001

Selective blocker of CFTR channel

 

GaTx2

10GTX002

Selective blocker of ClC-2 channel

 

 

乙酰膽堿受體(Acetylcholine receptor)

Toxin name

Catalog #

Target

Description

α-conotoxin PeIA

13CON017

α9α10, α3β2 subunits

 

αC-Conotoxin PrXA

13CON016

α1/β1/ε/δ, α1/β1/γ/δ subunits

 

Waglerin-1

12WAG001

MusclenAChR

 

α-conotoxin MI

08CON012

α1/δsubunits

 

α-conotoxin GI

08CON005

α/δsite

 

α-conotoxin IMI

08CON011

α7 homomeric nAChR

 

α-conotoxin GID

CON019

Blocker of α3β2, α7 and α4β2 nAChRs

 

 

N-甲基-D-天冬氨酸NR2B (NMDA, NR2B containing N-methyl-D-aspartate)

Conantokin-G選擇性、特異性抑制含NR2BNMDAR。Conantokin-G能劑量依賴性抑制Ca2+內(nèi)流,抑制NMDA誘導(dǎo)的興奮性中毒效應(yīng)。研究表明,在小鼠皮層神經(jīng)元,Conantokin-G阻滯NMDA引發(fā)的電流信號(hào)的IC50值為480 nM。

 

酸敏感離子通道(ASIC channel, Acid-Sensing Ion Channel)

Toxin name

Catalog #

Target

Description

APETx2

07APE002

Selective blocker of ASIC3

 

Psalmotoxin1/PcTx1

13PCT001

Selective blocker of ASIC1a

 

Ugr9-1

13UGR001

Blocker of ASIC3

 

 

瞬時(shí)受體電位(TRP channel, transient receptor potential)

Toxin name

Catalog #

Target

Description

GsMTx4

08GSM001

TRPC, TRPA

 

Vanillotoxin3

10VAN003

Activator of TRPV1

 

ProTx-I

12PTX001

Antagonist of TRPA1

 

 

嘌呤能通道(Purinergic channel)

Purotoxin-1

選擇性抑制P2X3受體。100 nM Purotoxin-1 (PT-1)選擇性抑制P2X3受體通道,在大鼠DRG神經(jīng)元上,使用膜片鉗實(shí)驗(yàn)表明:PT-1對(duì)電壓門(mén)控通道和TRPV1均無(wú)抑制效應(yīng)。10 μM ATP100 μM α,β Methylene-ATP濃度下Purotoxin-1對(duì)P2X3受體有選擇性作用,在該ATP濃度下Purotoxin-1對(duì)P2X2和雜化二聚體P2X2/3并無(wú)激動(dòng)作用。

Purotoxin-1對(duì)疼痛的潛在治療作用。

 

其它膜受體通道(Others)

Smartox Biotechnology還提供其他類型的膜受體抑制劑:

Toxin name

Catalog#

Target

Morphiceptin

011CAS001

Agonist of μ-opoid receptors

Lys-conopressin G

11CON14

Vasopressin-like peptide

GsMTx4

08GSM001

Mechano sensitive ion channels

Obtustatin

10OBT001

Blocks the binding of α1β1 integrin to collagen IV

Rho-Conotoxin TIA

CON022

Blocks α1-adrenergic receptor



  • 關(guān)于我們
  • 購(gòu)物流程
  • 支付方式
  • 配送方式

請(qǐng)打開(kāi)QQ掃碼聯(lián)系
Copyright@ 2003-2024  進(jìn)口試劑采購(gòu)網(wǎng)版權(quán)所有     

BIOLEAF熱搜   BIOLEAF試劑盒   BIOLEAF ELISA   BIOLEAF試劑   BIOLEAF品牌   BIOLEAF抗體   BIOLEAF耗材   BIOLEAF小儀器

sitemap   細(xì)胞庫(kù)查詢   危險(xiǎn)品圖標(biāo)

本公司網(wǎng)站所展示銷售的產(chǎn)品僅供科研!

         滬ICP備08023583號(hào)-6     
產(chǎn)品咨詢
QQ掃碼溝通
在線客服
服務(wù)電話
400-968-7988
掃碼關(guān)注
微信公眾號(hào)二維碼

滬公網(wǎng)安備 31011202007338號(hào)

| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |